147 related articles for article (PubMed ID: 8380685)
1. [Effect of radio-immunochemotherapy-using antiferritin antibody combined with anthracycline drugs on hepatocellular carcinoma cell].
Une Y; Sato Y; Alam S; Nagabuchi E; Hata Y; Uchino J
Gan To Kagaku Ryoho; 1993 Jan; 20(1):161-3. PubMed ID: 8380685
[No Abstract] [Full Text] [Related]
2. [131I antiferritin in the treatment of hepatoma and Hodgkin's disease].
Cohen Y; Moroz H
Harefuah; 1986 Dec; 111(11):398-9. PubMed ID: 3028919
[No Abstract] [Full Text] [Related]
3. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.
Hellman S
J Clin Oncol; 1985 Dec; 3(12):1569. PubMed ID: 2999345
[No Abstract] [Full Text] [Related]
4. Antiferritin immunoglobulin therapy for treatment of hepatoma.
Held J; McLaughlin P
Oncol Nurs Forum; 1987; 14(5):27-31. PubMed ID: 2821514
[No Abstract] [Full Text] [Related]
5. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.
Order SE; Stillwagon GB; Klein JL; Leichner PK; Siegelman SS; Fishman EK; Ettinger DS; Haulk T; Kopher K; Finney K
J Clin Oncol; 1985 Dec; 3(12):1573-82. PubMed ID: 2415692
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in the treatment of hepatocellular carcinoma.
Roh MS
Curr Opin Oncol; 1990 Aug; 2(4):725-30. PubMed ID: 1965691
[No Abstract] [Full Text] [Related]
7. Dosimetry and treatment planning in radioimmunotherapy.
Leichner PK; Yang NC; Wessels BW; Hawkins WG; Order SE; Klein JL
Front Radiat Ther Oncol; 1990; 24():109-20; discussion 121-2. PubMed ID: 2160407
[No Abstract] [Full Text] [Related]
8. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
[TBL] [Abstract][Full Text] [Related]
9. Dosimetry of 131I-labeled antiferritin in hepatoma: specific activities in the tumor and liver.
Leichner PK; Klein JL; Siegelman SS; Ettinger DS; Order SE
Cancer Treat Rep; 1983; 67(7-8):647-58. PubMed ID: 6307515
[TBL] [Abstract][Full Text] [Related]
10. [Radioimmunotherapy with 131 I-labeled humanized anti-HBsAg Fab and anti-nucleus antigen monoclonal antibody chTNT in nude mice bearing human hepatocellular carcinoma].
DU YF; Luo RC; Li GP; Li AM; Ding XM; Yan X; Huang K
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):460-2. PubMed ID: 18359714
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunotherapy of human hepatocellular carcinoma xenografts with 131I-labelled antiferritin antibody.
Saiful Alam AF
Br J Cancer; 1991 Apr; 63(4):503-7. PubMed ID: 2021533
[TBL] [Abstract][Full Text] [Related]
12. Antiferritin IgG antibody for isotopic cancer therapy.
Order SE; Klein JL; Leichner PK
Oncology; 1981; 38(3):154-60. PubMed ID: 6259569
[TBL] [Abstract][Full Text] [Related]
13. Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin. Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion.
Fan Z; Tang Z; Liu K; Zhou D; Lu J; Yuan A; Zhao H
J Cancer Res Clin Oncol; 1992; 118(5):371-6. PubMed ID: 1316355
[TBL] [Abstract][Full Text] [Related]
14. Immunoradiotherapy for primary nonresectable hepatocellular carcinoma.
Sitzmann JV; Order SE
Surg Clin North Am; 1989 Apr; 69(2):393-400. PubMed ID: 2538937
[TBL] [Abstract][Full Text] [Related]
15. Dosimetry and treatment planning for 90Y-labeled antiferritin in hepatoma.
Leichner PK; Yang NC; Frenkel TL; Loudenslager DM; Hawkins WG; Klein JL; Order SE
Int J Radiat Oncol Biol Phys; 1988 May; 14(5):1033-42. PubMed ID: 2834309
[TBL] [Abstract][Full Text] [Related]
16. Multicentre study of the treatment of primary liver cancer in Africa with two anthracycline drugs.
Kiire CF; Gombe-Mbalawa C; Tsega E; Luande J; Menenses LV; Okoth J; Olweny CL; Holland J
Cent Afr J Med; 1992 Nov; 38(11):428-31. PubMed ID: 1339230
[No Abstract] [Full Text] [Related]
17. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials.
Chen ZN; Mi L; Xu J; Song F; Zhang Q; Zhang Z; Xing JL; Bian HJ; Jiang JL; Wang XH; Shang P; Qian AR; Zhang SH; Li L; Li Y; Feng Q; Yu XL; Feng Y; Yang XM; Tian R; Wu ZB; Leng N; Mo TS; Kuang AR; Tan TZ; Li YC; Liang DR; Lu WS; Miao J; Xu GH; Zhang ZH; Nan KJ; Han J; Liu QG; Zhang HX; Zhu P
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):435-44. PubMed ID: 16690431
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second-look resection.
Tang ZY; Liu KD; Bao YM; Lu JZ; Yu YQ; Ma ZC; Zhou XD; Yang R; Gan YH; Lin ZY
Cancer; 1990 Jan; 65(2):211-5. PubMed ID: 1688507
[TBL] [Abstract][Full Text] [Related]
19. Hepatoma: model for radiolabeled antibody in cancer treatment.
Order SE; Klein JL; Leichner PK
NCI Monogr; 1987; (3):7-41. PubMed ID: 2434868
[TBL] [Abstract][Full Text] [Related]
20. Palliative chemoradiation in advanced hepatocellular carcinoma.
Bair RJ; Weis JR; Clayton F; Glasgow RE; Gaffney DK
J Clin Oncol; 2010 May; 28(15):e231-2. PubMed ID: 20308660
[No Abstract] [Full Text] [Related]
[Next] [New Search]